95 related articles for article (PubMed ID: 26186179)
1. Ovalbumin Delivery by Guanidine-Terminated Dendrimers Bearing an Amyloid-Promoting Peptide via Nanoparticle Formulation.
Kojima C; Kameyama R; Yamada M; Ichikawa M; Waku T; Handa A; Tanaka N
Bioconjug Chem; 2015 Aug; 26(8):1804-10. PubMed ID: 26186179
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.
Matsuo K; Koizumi H; Akashi M; Nakagawa S; Fujita T; Yamamoto A; Okada N
J Control Release; 2011 Jun; 152(2):310-6. PubMed ID: 21402114
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo.
Toyota H; Yanase N; Yoshimoto T; Harada M; Kato Y; Mizuguchi J
Oncol Rep; 2015 Jan; 33(1):292-6. PubMed ID: 25394516
[TBL] [Abstract][Full Text] [Related]
4. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo.
Sheng KC; Kalkanidis M; Pouniotis DS; Esparon S; Tang CK; Apostolopoulos V; Pietersz GA
Eur J Immunol; 2008 Feb; 38(2):424-36. PubMed ID: 18200633
[TBL] [Abstract][Full Text] [Related]
5. Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination.
Mittal A; Schulze K; Ebensen T; Weissmann S; Hansen S; Guzmán CA; Lehr CM
J Control Release; 2015 May; 206():140-52. PubMed ID: 25795506
[TBL] [Abstract][Full Text] [Related]
6. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells.
Ikehara Y; Shiuchi N; Kabata-Ikehara S; Nakanishi H; Yokoyama N; Takagi H; Nagata T; Koide Y; Kuzushima K; Takahashi T; Tsujimura K; Kojima N
Cancer Lett; 2008 Feb; 260(1-2):137-45. PubMed ID: 18077084
[TBL] [Abstract][Full Text] [Related]
7. Role of the N-terminal amphiphilic region of ovalbumin during heat-induced aggregation and gelation.
Kawachi Y; Kameyama R; Handa A; Takahashi N; Tanaka N
J Agric Food Chem; 2013 Sep; 61(36):8668-75. PubMed ID: 23909792
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of biodegradable nanoparticles with aluminum adjuvants: antigen uptake by dendritic cells and induction of immune response in mice.
Uto T; Akagi T; Toyama M; Nishi Y; Shima F; Akashi M; Baba M
Immunol Lett; 2011 Oct; 140(1-2):36-43. PubMed ID: 21693134
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapy.
Pandey RS; Sahu S; Sudheesh MS; Madan J; Kumar M; Dixit VK
Int Immunopharmacol; 2011 Aug; 11(8):925-31. PubMed ID: 21333772
[TBL] [Abstract][Full Text] [Related]
10. Intracellular degradation and distribution of protein-encapsulated amphiphilic poly(amino acid) nanoparticles.
Akagi T; Shima F; Akashi M
Biomaterials; 2011 Jul; 32(21):4959-67. PubMed ID: 21482432
[TBL] [Abstract][Full Text] [Related]
11. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
[TBL] [Abstract][Full Text] [Related]
12. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of vaccine to dendritic cells by chitosan nanoparticles conjugated with a targeting peptide ligand selected by phage display technique.
Jung SN; Kang SK; Yeo GH; Li HY; Jiang T; Nah JW; Bok JD; Cho CS; Choi YJ
Macromol Biosci; 2015 Mar; 15(3):395-404. PubMed ID: 25393207
[TBL] [Abstract][Full Text] [Related]
14. Near-infrared labeled, ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: In vivo tracking and evaluation of antigen-specific CD8(+) T cell immune response.
Rahimian S; Kleinovink JW; Fransen MF; Mezzanotte L; Gold H; Wisse P; Overkleeft H; Amidi M; Jiskoot W; Löwik CW; Ossendorp F; Hennink WE
Biomaterials; 2015 Jan; 37():469-77. PubMed ID: 25453974
[TBL] [Abstract][Full Text] [Related]
15. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
[TBL] [Abstract][Full Text] [Related]
16. Amphiphilic nano-delivery system based on modified-chitosan and ovalbumin: Delivery and stability in simulated digestion.
Li L; Sun X; Zhang H; Dong M; Wang J; Zhao S; Shang M; Wang X; Zhangsun H; Wang L
Carbohydr Polym; 2022 Oct; 294():119779. PubMed ID: 35868755
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization.
Stano A; Nembrini C; Swartz MA; Hubbell JA; Simeoni E
Vaccine; 2012 Dec; 30(52):7541-6. PubMed ID: 23103199
[TBL] [Abstract][Full Text] [Related]
18. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
Wang X; Uto T; Akagi T; Akashi M; Baba M
J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
[TBL] [Abstract][Full Text] [Related]
19. Alginate Particles with Ovalbumin (OVA) Peptide Can Serve as a Carrier and Adjuvant for Immune Therapy in B16-OVA Cancer Model.
Zhu L; Ge F; Yang L; Li W; Wei S; Tao Y; Du G
Med Sci Monit Basic Res; 2017 Apr; 23():166-172. PubMed ID: 28450696
[TBL] [Abstract][Full Text] [Related]
20. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
Gordon S; Saupe A; McBurney W; Rades T; Hook S
J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
